Biotech news for Friday, May 22, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Earnings Call Insights: Roivant Sciences Ltd. (ROIV) Q4 2025 Management View CEO Matthew Gline said the quarter included “the preliminary open-label period data from the 1402 study in D2T RA” and a “planned spotlight… on mosliciguat,” alongside “some smaller u…
hapabapa BioMarin Pharmaceutical ( BMRN ) is up ~3% in after-hours trading Wednesday after posting phase 3 data for Voxzogo (vosoritide) in children with hypochondroplasia that met its primary endpoint. Children given the treatment saw a statistically signific…
Worawith Ounpeng Soon after reaching a research pact worth up to $2.3B with Regeneron ( REGN ), clinical-stage biopharma Parabilis Medicines ( PBLS ) has submitted regulatory filings with the Securities and Exchange Commission seeking a U.S. IPO. According to…
Hailshadow/iStock via Getty Images Dyne Therapeutics ( DYN ) traded higher on Wednesday after the company announced the launch of a late-stage trial to evaluate zeleciment rostudirsen (z-rostudirsen/DYNE-251), its experimental therapy for Duchenne muscular dys…
mohd izzuan/iStock via Getty Images Roivant Sciences ( ROIV ) traded sharply higher after its subsidiary Immunovant ( IMVT ) posted initial results from a Phase 2 trial evaluating its lead asset IMVT-1402 in rheumatoid arthritis, an autoimmune disorder affecti…
Annovis Bio ( ANVS ) shares fell over -7% on Wednesday after the biotechnology company priced an offering to raise approximately $15M. The offering consists of 7,895,000 shares of its common stock and accompanying warrants to purchase up to 7,105,500 shares. T…
Lunai Bioworks ( Nasdaq: LNAI ) on Wednesday said it will implement a 1-for-8 reverse stock split of its common stock effective May 22. The company said its shares will continue trading on the Nasdaq Capital Market under the symbol “LNAI” on a split-adjusted
Incyte ( INCY ) and Genesis Molecular AI announced on Wednesday that they are expanding their AI drug discovery partnership to speed up new small-molecule medicines development via Genesis’ GEMS platform. As part of the deal, Incyte will share its proprietary…
Grandbrothers/iStock Editorial via Getty Images ImmunityBio ( IBRX ) added ~9% in the premarket on Wednesday after the U.S. Food and Drug Administration accepted its marketing application aimed at expanding the label of its bladder cancer therapy, Anktiva. The…
Alps Group ( Nasdaq: ALPS ) on Tuesday said it received a notice from Nasdaq Stock Market stating it was not in compliance with the exchange's minimum bid price requirement. Nasdaq said the company's shares had closed below the required minimum bid
Amgen ( AMGN ) announced the retirement of executive vice president and chief financial officer Peter Griffith after serving in the role since 2020. Thomas Dittrich will rejoin Amgen as executive vice president on July 1 and become chief financial officer effe…